Corbus Pharmaceuticals Holdings, Inc. Number of Operating Segments
Corbus Pharmaceuticals Holdings, Inc. (CRBP) reported Number of Operating Segments of 1 Segment for the 6-month period ending 2020-06-30, per its 10-Q filed 2020-08-06.
Discontinued › Notes
us-gaap:NumberOfOperatingSegments · last filed 2020-08-06
- Corbus Pharmaceuticals Holdings, Inc. number of operating segments for the quarter ending 2020-03-31 was 1.00 Segment, a 0.00% change year-over-year.
- Corbus Pharmaceuticals Holdings, Inc. number of operating segments for the quarter ending 2019-03-31 was 1.00 Segment, a 0.00% change year-over-year.
- Corbus Pharmaceuticals Holdings, Inc. number of operating segments for the quarter ending 2018-03-31 was 1.00 Segment, a 0.00% change year-over-year.
- Corbus Pharmaceuticals Holdings, Inc. number of operating segments for the quarter ending 2017-03-31 was 1.00 Segment, a 0.00% change year-over-year.
- Corbus Pharmaceuticals Holdings, Inc. number of operating segments for fiscal 2019 was 1.00 Segment, a 0.00% change from fiscal 2018.
- Corbus Pharmaceuticals Holdings, Inc. number of operating segments for fiscal 2018 was 1.00 Segment, a 0.00% change from fiscal 2017.
- Corbus Pharmaceuticals Holdings, Inc. number of operating segments for fiscal 2017 was 1.00 Segment, a 0.00% change from fiscal 2016.
- Corbus Pharmaceuticals Holdings, Inc. number of operating segments for fiscal 2016 was 1.00 Segment, a 0.00% change from fiscal 2015.
| Period end | Number of Operating Segments 3 month | Number of Operating Segments 6 month | Number of Operating Segments 9 month | Number of Operating Segments 12 month |
|---|---|---|---|---|
| 2020-06-30 | 1.00 Segment 10-Q · filed 2020-08-06 | |||
| 2020-03-31 | 1.00 Segment 10-Q · filed 2020-05-11 | |||
| 2019-12-31 | 1.00 Segment 10-K · filed 2020-03-16 | |||
| 2019-09-30 | 1.00 Segment 10-Q · filed 2019-11-07 | |||
| 2019-06-30 | 1.00 Segment 10-Q · filed 2019-08-08 | |||
| 2019-03-31 | 1.00 Segment 10-Q · filed 2019-05-09 | |||
| 2018-12-31 | 1.00 Segment 10-K · filed 2019-03-12 | |||
| 2018-09-30 | 1.00 Segment 10-Q · filed 2018-11-08 | |||
| 2018-06-30 | 1.00 Segment 10-Q · filed 2018-08-08 | |||
| 2018-03-31 | 1.00 Segment 10-Q · filed 2018-05-10 | |||
| 2017-12-31 | 1.00 Segment 10-K · filed 2018-03-12 | |||
| 2017-09-30 | 1.00 Segment 10-Q · filed 2017-11-08 | |||
| 2017-06-30 | 1.00 Segment 10-Q · filed 2017-08-09 | |||
| 2017-03-31 | 1.00 Segment 10-Q · filed 2017-05-09 | |||
| 2016-12-31 | 1.00 Segment 10-K · filed 2017-03-08 | |||
| 2016-09-30 | 1.00 Segment 10-Q · filed 2016-11-10 | |||
| 2016-06-30 | 1.00 Segment 10-Q · filed 2016-08-12 | |||
| 2016-03-31 | 1.00 Segment 10-Q · filed 2016-05-13 | |||
| 2015-12-31 | 1.00 Segment 10-K · filed 2016-03-28 | |||
| 2015-09-30 | 1.00 Segment 10-Q · filed 2015-11-10 | |||
| 2015-06-30 | 1.00 Segment 10-Q · filed 2015-08-13 | |||
| 2015-03-31 | 1.00 Segment 10-Q · filed 2015-05-13 | |||
| 2014-12-31 | 1.00 Segment 10-K · filed 2015-02-10 | |||
| 2014-09-30 | 1.00 Segment 10-Q · filed 2014-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |